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Using a serum sample of a bullous pemphigoid (BP) patient 
we have isolated a cDNA clone encoding a portion of a 
I80-kD polypeptide component of the hemidesmosome, the 
"BP180 autoantigen." The identity of the clone was con-
firmed by the generation of a fusion protein antibody that 
recognizes BP180 in both a basal epithelial cell extract of 
bovine tongue and extracts of human epidermal cells. Im-
munoelectron microscopy indicates that the 588-bp cDNA 
encodes a cytoplasmic fragment ofBP180. Furthermore, the 
wide species reactivity of the fusion protein suggests that this 
portion of BP180 is highly conserved. In cultured human 
epidermal cells processed for confocal immunofluorescence 
microscopy, the fusion protein antibody generates a punctate 
cell substrate-associated staining pattern that is similar to that 
seen using BP230 antibodies. Using the original BP180 
T he sera of patients with bullous pemphigoid (BP) con-tain autoantibodies against components of an adher-ens junction termed the hemidesmosome [1-5]. This junction is located ",long the basal surface of basal epithelial cells and is involved in the interaction of the 
epithelial cell with the basement membrane zone [6] . Furthermore, 
the cytoplasmic plaque of the hemidesmosome acts as a cell-surface 
anchorage site for bundles of keratin-containing intermediate fila-
ments [6]. The finding that hemidesmosome structure is perturbed 
in certain skin diseases such as BP and junctional epidermolysis 
bullosa provides evidence, albeit indirect, that hemidesmosomes 
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bp: base pair 
BP: bullous pemphigoid 
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NHEK: normal human epidermal keratinocytes 
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SCC: squamous cell carcinoma 
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resis 
eDNA we have now isolated additional eDNA clones encod-
ing approximately 1800bp of BP180 the 3' sequence of 
whieh overlaps with the sequence detailed in Giudice et al (J 
Clin Invest 87:734-738, 1991). Secondary structural analy-
ses have been undertaken on the predicted amino acids en-
coded by the 1800bp. These suggest that the collagen-like 
sequences of BP180 described by Giudice et al (ibid.) are 
separated by a putative transmembrane region from the do-
main of BP180 recognized by our fusion protein antibody. 
Indeed, BP180 appears to belong to a relatively rare group of 
proteins in which the N-terminus is located in the cytoplasI? 
and the C-terrninus is extracellular. We detail some preli~l­
nary biochemical experiments in support of this hypothes1S • 
We discuss possible functions of BP180 .and BP230 in the 
hemidesmosome.] Invest DermatoI99:264-270, 1992 
play an important role in the maintenance of epidermal-connective 
tissue integrity [7,8] . 
It has become apparent that there are two major BP antigens.of 
180 and 230 kD in epidermal cells [9,10]. Klatte et al [5] affinity 
purified autoantibodies against BP180 and BP230 using a basal epi-
thelial cell extract as an antigenic source. These workers were then 
able to show that BP180 and BP230 are immunologically distinct 
and that both are components of the electron-dense cytoplasmiC 
plaque of the hemidesmosome. More recently, using fusion prote1l1] 
or peptide antibodies against BP230 and BP180, Tanaka et al [1 ~ 
and Diaz et al [12] have confirmed that these polypeptides reside III 
the hemidesmosome. 
Using BP autoantibodies, we have isolated clones encoding 
BP180 from a lambda gtl1 keratinocyte expression library. We 
present a partial sequence of BP 180 that overlaps with the seque?ce 
detailed by Giudice et al [13] and that is 5' to the sequence encodl:? 
a certain collagen-like domain of this antigen. We have generate . a 
BP180 fusion protein antibody that recognizes the cytoplasmiC 
plaque of the hemidesmosome as determined by immunoeiectron 
microscopy. Taken together, the results we present here and th~se 
of Giudice et al [13] suggest that BP180 is a transmembrane prote1l1i 
with its N-terminus in the cytoplasm. We provide biochemlca 
evidence that the cytoplasmic domain of BP180, which is rec~­
nized by our fusion protein antibody, is approximately 55 kD. e 
discuss the role of BP180 in the function of the hemidesmosome 
and contrast this with the proposed role of BP230. 
MATERIALS AND METHODS 
ur-Cell Culture Normal human keratinocytes (NHEK) were p 
chased from Clonetics Corp. (San Diego, CA). SCC12 F2cells were 
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~igure 1. cDN A and predicted amino acid sequence of a portion ofBP180. Tips oJthe arrows, position of the original 588-bp cDNA that was isolated from the 
b eratll10cyte lambda gtll library. The fusion protein used for antibody preparation is encoded by this sequence. The region of the sequence indicated by the 
:oketl/ine overlaps with the 3' sequence detailed by Giudice et al [13]. Solid lilIes, regions of high hydrophobicity, v, poss ible phosphorylation sites; x, possible 
Site of phosphorylation by p34,d'2 kinase; 0, four cysteine residues between the two regions of hydrophobicity. 
originally derived by Dr. James Rheinwald and were a gift from Dr. 
Amy Paller, Children's Memorial Hospital, Chicago, IL. The 
NBEK and SCC12 cell lines were maintained in keratinocyte 
growth medium (KGM, Clonetics Corp.). 
"fissue Material Normal human skin was provided by Dr. Frank 
Carone of Northwestern University Medical School. Rat tissues 
Were. provided by Dr. James Bartles of Northwestern University ~edlcal School. Bovine material was purchased from Dutch :V:alley 
tal of Dolton, IL. Frog skin was provided by Dr. Eugene SlllllSky 
o Northwestern University Medical School. 
~creening of a Human Keratinocyte Lambda gtll Library Sth~ human keratinocyte library was the generous gift of Dr. Peter 
ell1ert of the NIH. It was screened with a BP serum sample con-
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F· l e~gure 2. Comparison of a portion ofBP180 sequence (indicated in a single 
ch ter code) (u]!]!er) with a region of the predicted amino acid sequence of a 
Whcken collagen (lower) [25]. Sit/gle litles between residues indicate identity 
ereas dots between residues indicate similar residues. 
taining autoantibodies against both BP180 and BP230 (see below), 
according to Huynh et al [14]. To further characterize positive 
clones, plaque lifts of nitrocellulose-bound fusion protein were used 
to epitope select antibodies[15]. The library was rescreened with 
32P-random-primer-labeled cDNA probes Multiprime DNA La-
beling System (Amersham, Arlington Heights, IL). 
Sequencing cON A inserts were subcloned into M 13 vectors and 
sequenced by the Sanger dideoxy chain termination method [16] , 
using the USB Sequenase kit (USB, Cleveland, OH). Sequence 
analyses and secondary structural predictions were made using the 
GCG sequence analysis software package (University of Wisconsin 
Biotechnology Center, Madison, WI). 
Antibodies The BP serum, which contains autoantibodies 
against both BP180 and BP230, was provided by Dr. Ruth Frienkel 
of Northwestern University Medical School (see below) . BP230 
autoantibodies from a BP serum have been detailed previously 
[5,17]. 
A cDNA insert encoding 588 bp of 180BP antigen was subcloned 
into the Eco R 1 site of the pATH1 vector and transfected into 
HBI0l cells [18]. A trpE fusion protein was induced as previously 
described [18] and the cells containing the fusion protein were pro-
cessed for SDS-PAGE (see below). The fusion protein was identi-
fied on the sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE) gel following staining in Coomassie Brilliant 
Blue (Sigma Chemical Co., St. Louis, MO) and was excised. The gel 
pieces were homogenized and injected into a rabbit for the genera-
tion of a polyclonal rabbit serum. In addition, some of the gel slices 
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Figure 3. Western immunoblotting analysis of the BP180 fusion protein 
antibody. Extracts ofNHEK (lanes A, D, and G) and SCC12 cells (lanes B, E, 
and II) and a bovine tongue basal epithelial cell extract (latJes C, F, and 1) (at 
approximately 20,u1 per latJe) were processed for SDS-PAGE and the sepa-
rated polypeptides were transferred to nitrocellulose. Lanes A-C are the 
amido black stains of the transferred proteins. LaJlfs D-F and lanes G-I are 
immunoblots using the BP180 fusion protein antibody and a BP serum 
sample, respectively. Note that the fusion antibodies recognize a single 
polypeptide of 180 kD, whereas the BP serum sample contains autoantibo-
dies that recognize both 230- and 180-kD polypeptides. 
were used to immunize mice and an IgM monoclonal antibody was 
prepared against the fusion protein as detailed elsewhere. * 
Protein Preparations The basal cell extract enriched in hemi-
desmosomal .components was prepared from bovine tongue epithe-
liUln as detailed in Klatte et al [5]. The extracts of cultured cells were 
prepared as detailed in Riddelle et al [19]. 
Immunofluorescence Cells grown on glass coverslips were 
fixed for 2 min in -2_oC acetone and air dried. Tissue material was 
snap frozen in liquid nitrogen, 8-,um-thick sections were prepared 
using a Tissue Tek cryo microtome, and the sections placed on 
microscope slides. The sections were fixed for 5 min in -20°C 
acetone and air dried. A 1:50 dilution of the rabbit fusion protein 
antiserum was overlaid on the cells or tissue sections, which were 
incubated at 37°C for 1 h . After thorough washing, the cells on 
coverslips and sections were incubated for a further 1 h at 37°C in 
fluorescein-conjugated goat anti-rabbit IgG (Kirkegard and Perry). 
For double labels, the cells on covers lips were first incubated in a 
mixture of primary antibodies and then, after washing, were incu-
bated in a mixture of fluorescein-conjugated goat anti-rabbit IgG 
and rhodamine-conjugated goat anti-human IgG (Kirkegard and 
Perry). The sections and cells on coverslips were viewed using ei-
ther a Zeiss Photomicroscope III fitted with epifluorescence and 
phase optics or a Zeiss laser scan confocal microscope (LSMI0). 
Photomicrographs were made using Kodak Plus X film, which was 
developed in a Diafine two-stage developer. 
Immunoelectron Microcopy Cryostat sections of normal 
human skin were prepared, placed on glass slides, fixed in -20°C 
acetone for 5 min, and then air dried. The fusion antibody diluted 
1:20 in phosphate-buffered saline (PBS) was overlaid on the sec-
tions, which were then incubated for 1 h at 37°C. After thorough 
washing, the sections were incubated in 5-nm gold conjugated goat 
anti-rabbit antibody for 6 h at room temperature. The sections were 
then processed for electron microscopy as previously detailed [5]. 
Thin sections of material were prepared using an Ultracut E ultra-
microtome and viewed in aJEOL 100CX electron microscope at an 
accelerating voltage of 60 kV. 
50S-PAGE and Western Immunoblotting The bovine basal 
epithelial cell preparation and cultured cell extracts were processed 
• Riddelle, Hopkinson, Jones (submitted for publication). 
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for SDS-PAGE on 7.5% polyacrylamide gels according to Laemmli 
[20]. Proteins were transferred from the gels to nitrocellulose ac-
cording to Towbin et al [21]. Immunoblotting was carried out as 
detailed in Zackroff et al [22]. 
RESULTS 
Isolation of BP180 cDNA and Sequence Determination 
Twenty-five positive clones were isolated from a keratinocyte 
lambda gtl1 library using a BP serum (see below for the immuno-
blotting reactivity of this particular serum) and plaque purifi~d. 
Epitope selection revealed that, of these clones, two contained 111-
serts encoding BP230 whereas one contained a 588-bp cDNA insert 
encoding a portion of the BP180. This 588-bp fragment was used to 
rescreen the library. Several overlapping clones were identified t~at 
further extended the sequence to a total of 1779 bp. The entire 
sequence that we have obtained to date is shown in Fig 1. 
Translation of this sequence reveals that it contains an open read-
ing frame extending the entire 1779 bp. A possible A TG start codon 
is located at bases 73- 75 (Fig 1). Secondary structural analyses were 
performed using GCG software. There are two regions of hydro-
phobicity in the predicted amino acid sequence stretching from 
amino acid 456 through 480 and 489 through 514. Both are 5' to 
the portion of our sequence that overlaps with the partial sequen~e 
of BP180 detailed in Giudice et al [13] (Fig 1). We indicate SIX 
possible substrate recognition sites for protein kinases [23] (Fig 1). 
In addition, there is a possible site for phosphorylation by p34cd.c2 
protein kinase at serine residue 199 [24] (Fig 1). A 125 _amino-acl~ 
stretch ofBP180 beginning at residue 469 shows 55% identity an 
80% homology with a portion of the predicted amino acid sequence 
of a chicken corneal protein [25] (Fig 2). 
Immunochemical Characterization of the Fusion Protein 
Antibody To confirm that the clones we identified encode 
BP180, the 588-bp cDNA insert of our first clone was expressed as a 
fusion protein (see Materials and Methods) against which we prepare.d 
both monoclonal and polyclonal antibodies. The monoclonal anti-
body will be described elsewhere. * Polyclonal rabbit serum that was 
produced recognizes a single 180-kD polypeptide on immunobl~tS 
of human epidermal cell extracts as well as a preparation of bov1l1e 
tongue basal epithelial cells enriched in hernidesmosome compod 
nents (Fig 3). Furthermore, this 180-kD polypeptide is recog~lze 
on comparable blots by autoantibodies in a BP serum sample (FI~ 3). 
It should be noted that the same BP serum also contains autoantlb~­
dies against the 230-BP antigen (Fig 3). The fusion protein anti-
body, on the other hand, fails to recognize BP230. 
We have undertaken a limited tissue and species immunofluo(es-
cence survey using this fusion antibody. The antibody recognize} 
the interface between the epithelium and connective tissue 0 
human skin and bovine tongue mucosa (Fig 4). The antibody g.ener-
ates a similar staining pattern in frog skin (Fig 4). In rat, the antibody 
recognizes the epithelium-connective tissue interface in skin, tla-chea, bladder and cornea but not intestine (results not shown). T le 
antibody also recognizes basement-membrane components In 
human mammary tissue (result not shown) . . 
In the cultured human epidermal cell line SCC12 the fus lO:! 
protein antibody generates staining along the substrate-att.ache 
surface of cells (Fig 5). Figure 5 shows a confocal microscope Ima~e 
of sec 12 cells processed for double labeling using BP230 autoantl: 
bodies and the fusion protein antibody. D" in Fig 5 is a co~pute~ 
generated z-section of the cells revealing that BP180 antlgen;s 
distributed along the region where the cell is in contact with t e 
glass coverslip. It is remarkable that the surface-staining 'pat~er~ 
generated by both the fusion protein and BP230 antibodies 510 
continuity from cell to cell (Fig 5). . d 
At the electron-microscopic level, the fusion protein antlbo ~ 
binds to the cytoplasmic portion of the plaque of hemidesmosOrn:e 
of human skin (Fig 6). Gold particles are concentrated over t 
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Figure 4. Cryosections of human skin (A), bovine tongue (B), and frog skin (C) were processed for immunofluorescence microscopy using the fusion protein 
antibody. Note tha~ in each of these tissues the antibodies generate staining along the epithelial (E), dermal (D) border. Bar, 30I.l.m. 
region of the plaque to which keratin bundles attach (Fig 6). No 
gold particles are observed at the extracellular face of the hemides-
tnosome (Fig 6). 
Trypsin Digestion of BP180 in Epithelial Cells We have 
f?llowed the fate of both BP180 and BP230 following trypsiniza-
tl~n of human epidermal cells. Confluent epidermal cells main-
tained on tissue-culture plastic were rinsed briefly in PBS and then 
treated for 5 min in 0.05% trypsin in PBS. The cells were removed 
frorn the dish by aspiration and collected by centrifugation. The 
trypsin sOlution was inactivated by briefly washing the cells in tis-
sue-culture medium containing 10% fetal calf serum. Over 95% of 
the cells are viable following such treatment as assessed by vital dye 
staining. 
Extracts of freshly trypsinized epidermal cells and, as a control, 
extracts of intact confluent monolayers of cells, were processed for 
I~rnunoblotting using the fusion-protein antibody and a BP serum 
(Fig 7). The BP serum recognizes BP230 in both the trypsinized 
and rnonolayer extract. However, this same serum fails to recognize 
BP180 in the trypsinized preparation (Fig 7). The latter is also the 
case for the fusion protein. Indeed, the fusion protein antibodies and 
autoantibodies in the BP serum recognize a 55-kD species in the 
trypsinized cell extract (Fig 7). This low - molecular-weight species 
IS absent in the extract of the cell monolayer (Fig 7). 
DISCUSSION 
In this study, we detail the sequence for a portion of the epidermal 
autoantigen BP180. We have confirmed that the clones we have 
Isolat~d encode for this polypertide by the production of a fusion 
proteul antibody. Giudice et al 13) have already described a partial 
sequence for BP180 and the 3' region of the BP180 sequence that 
We present here overlaps with their 5' sequence. Giudice (personal 
~?rnrnunication) has recently derived another 2000 bp of sequence 
to. the published data . All told, this makes about 4800 bp of open 
;eadlng frame. This would encode a polypeptide of approximately 
60 kD, 20 kD short of the apparent molecular weight ofBP180 on 
rolyacrylamide gels . It is possible that some of this missing molecu-
ar weight may be accounted for by post-translational modifications B~h as glycosylation, particularly as our data supports the idea that 
th 180 possesses an extracellular domain (see below). Certamly, 
ere IS a potential start codon (ATG) towards the 5' of our se-rtuen~e. Furthermore, G residues in the -9, -3, and +4 positions thnkln~ this codon are consistent with the consensus sequence for 
e initiation of translation according to Kozak [26]. However, we ~annot rule out the possibility that we may still lack 5' sequence. We 
dre .currently attempting to purify BP180 so that we can chemically 
ertve the sequence of its N-terminus. 
An analysis of the predicted amino acid sequence ofBP180 indi-
cates that it contains two regions of high hydrophobicity beginning 
at residues 456 and 489. Both these are potential transmembrane 
domains or regions of close BP180 apposition to the plasma mem-
brane. Giudice et al [13] have shown that the carboxy terminus of 
BP180 possesses collagen-like domains. Furthermore, an antibody 
that these workers have generated against a region ofBP180 close to 
these domains appears to localize to the lamina lucida side of the 
hemidesmosome.* Our antibody recognizes an epitope of BP180 
that is located towards the N-terminus of the molecule, separated 
from the collagen-like domains by the regions of high hydrophobi-
city. Moreover, our fusion protein antibody binds to the cytoplas-
mic face of the hemidesmosome. Together these results argue 
against the possibility that there are two membrane-spanning do-
mains with both the N- and C-terminus being cytoplasmic. Rather, 
they strongly suggest that the N-tenninus ofBP180 is cytoplasmic, 
whereas the C-terminus is extracellular. This is the orientation of 
only about 5% of transmembrane proteins. Other examples include 
the type I and type II macrophage scavenger receptors. Remarkably, 
the latter proteins, like BP180, possess extracellular collagen-like 
domains [27,28]. 
The results from our trypsin-digestion experiments support that 
BP180 is an integral membrane with both cytoplasmic and extracel-
lular domains. There are many possible trypsin digestion sites in the 
putative extracellular domain of BP180. Some of these are located 
close to the predicted transmembrane region of the molecule. We 
presume that the only portion of BP 180 that would be sensitive to 
trypsin in the experiments we have undertaken would lie outside 
the cell. Thus the residue of trypsin digestion of BP180 would be 
the cytoplasmic domain and the membrane-spanning region, which 
together have a predicted molecular weight of either 50 or 54 kD, 
depending upon which of the two hydrophobic domains actually 
spans the membrane. Because the molecular weight of the trypsin 
product is closer to the higher of these two figures, we propose that 
the transmembrane domain begins at residue 489, rather than 456. 
It should be noted that, in contrast to BP180, BP230 is apparently 
unaffected by trypsin treatment. This strongly suggests that BP230 
is entirely cytoplasmic. If this is the case, then the small 17 hydro-
phobic amino acid stretch that certain authors have noted towards 
the C-terminus of BP230 is more likely to function as a membrane 
anchor for the molecule rather than a membrane-spanning region, 
as Sawamura et al [29] have suggested. 
Within the putative cytoplasmic domain ofBP180 there are sev-
• Giudice (personal communication). 
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Figure 5. SCC12 cells were processed for double-label immunofluorescence using BP230 autoantibodies (A) and the BP180 fusion protein antibody (B!~) ' 
The preparation was viewed in a confocal microscope. C, phase-contrast image of the cells for orientation. The staining patterns in A and B are essent1a~ Y 
identical. D' shows a portion of the image shown in C. While lillc, region where a computer-generated z-section was made and this is shown in D". Note. t . ~ t 
the staining generated in the cell is close to the substrate (large arrow). The apical surface of the cell (i.e., the surface of the cell opposite the glass covershp) IS 
indicated by small arrows. Bar, 10 11m. 
eral potential phosphorylation sites as well as a consensus sequence 
for recognition by p34cdc2 kinase. The latter enzyme is involved in 
the initiation of mitotic and meiotic M phase [24]. In this regard, it is 
likely that as a cell enters the M phase of the cell cycle, there may be 
modifications in cytoskeletal-hemidesmosome linkage and/or he-
midesmosome-matrix interactions. Moreover, hemidesmosomes 
may even disassemble. It will now be of interest to determine 
whether phosphorylation ofBP180 by p34cdc2 kinase plays a role in 
these phenomena in much the same way that it is involved in nu-
clear lamina disassembly and reorganization of the cytoskeleton 
(24). 
The fusion protein antibody recognizes those tissues, such as epi-
dermis, bladder, trachea, and mammary glands, that contain hemi-
desmosomes. The antibody fails to recognize tissues such as the 
intestine, which do not possess bona fide hemidesmosomes. The 
antibody shows considerable species cross-reactivity, as it recognizes 
amphibian as well as mammalian epidermis. This suggests to us that 
the N-terminus ofBP180 is conserved and may playa crucial role in 
the function ofBP180. It presumably contributes to the structure of 
the plaque and may be involved in BP180 interactions with other 
elements in the plaque such as BP230, the cytoplasmic domains of 
aJj4 integrins, or a hemidesmosomal polypeptide of 200 kD char-
acterized by Kurpakus and Jones [17] . Of course, the cytoplas~IC 
domain of BP180 may be involved in the linkage of intermedl~r 
filaments to the hemidesmosomal plaque, a role that has alrea . Y 
been suggested for BP230 and the cytoplasmic tail of P4 integfl:! 
[30,31]. It should be noted that four cysteine residues are locati 
close to the putative membrane-spanning domain of the mol~~t ~ 
and these may be involved in cross linking BP180 to other heml es 
mosomal plaque elements. Alternatively, these cysteine residrs 
may playa role in the homophilic association of BP180 molecu IS; 
A portion of the putative cytoplasmic region and the extracel~u a 
domain of BP180 shows a high amino acid sequence hon;t0 dg; 
with the partial sequence presented for a collagen characteflZe 'n 
the molecular level in chick cornea [25). In fact this chick protei 
may well be the avian form of BP180. . 180 
We have already discussed the evidence that our orig,nal .B~ e 
eDNA clone encodes a cytoplasmic portion of BP180. ThiS c oro 
was identified using BP180 autoantibodies. Klatte et al (5) a ~c 
showed that BP autoantibodies appear to recognize cytoplasm' 
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Figure 6. Immunogold localization of the fusion protein antibody on a 
ctyOsection of human skin. Gold particles are concentrated on the cytoplas-;IC aspect of hemidesmosomal plaques (small arrows). IF, keratin interme-
diate filaments; E, epidermal cell ; D , Dermis; LL, Lamina IU':lda; LD, lamina 
cnsa. Bar, 250 nm. 
hpitopes of EP180 by immunoelectron microscopy. On the other 
and, the EP180 eDNA clones that Diaz et al [12] and Giudice et al 
[13] identified using EP autoantibodies encode the putative extra-
cellular domains of the molecule. This is of interest because it im-
plies that either EP patients possess distinct immuno-reactivities 
With BP180 or that their immune response to EP180 is a polyclonal 
one. 
1 Bp autoantibodies may playa causative role in EP pathogenesis 
~i though this remains co~troversial. Certainly, it is diffi.cul~ to ~e­
eve that EP230 autoantibodies and those EP180 autoantIbodles 
-' --
A B c o E F 
Figu 7 (<1 re . Extracts of SCC12 cells prepared from an intact cell monolayer 
pe~ f' and E) or freshly trypsinized SCC12 cells (B, D, and F) (about 20,u1 
n' ane) were processed for SDS-PAGE and subsequently transferred to 
Lltrocellulose. La/les A and B show amido black stains of transferred proteins. 
p:IJes. C and D and lalles E and F are immunoblots using the BP180 fusion 
all~.~ln antibodies and a BP serum, respectively. Note that the fusion protein 
th I SOdles and the BP autoantibodies strongly stain a 180-kD polypeptide in 
..,: k CC12 cells in lalles C and E. However, both antibody samples only 
latta ly recognize a comparable polypeptide in lalles D and F. Rather, in the 
aUt Cr lanes, they recognize a polypeptide of around 55 kD. Note that the BP 
ando~ntlbodies show comparable reactivity with BP230 in both the intact 
typslll1zed cell preparations (la/les E and F) . 
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which recognize cytoplasmic epitopes, could playa role in blister 
formation [5). Indeed, much more likely candidates for causative 
agents in the disease are those EP 180 autoantibodies against the 
extracellular domains ofEP180 that Diaz et al [1 2] and Giudice et al 
[13] have identified. 
In summary, we have undertaken a cell and molecular study of 
EP180. This protein appears to be a type II transmembrane protein 
with a conserved cytoplasmic domain. It is now our goal to analyze 
the protein-protein interactions of' both the cytoplasmic and extra-
cellular domains of EP180. This should provide new insights into 
the structure of the hemidesmosome and its role as a connector of 
the epidermis to the basement membrane zone. 
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